GoodRx Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Public

  • Employees
  • 697

Employees

  • Stock Symbol
  • GDRX

Stock Symbol

  • Investments
  • 10

  • Share Price
  • $3.51
  • (As of Thursday Closing)

GoodRx General Information

Description

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Contact Information

Website
www.goodrx.com
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 2701 Olympic Boulevard
  • West Building Suite 200
  • Santa Monica, CA 90404
  • United States
+1 (855)
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Information Services (B2C)
Outcome Management (Healthcare)
Other Healthcare Technology Systems
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 2701 Olympic Boulevard
  • West Building Suite 200
  • Santa Monica, CA 90404
  • United States
+1 (855)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GoodRx Stock Performance

As of 12-Nov-2026, GoodRx’s stock price is $3.51. Its current market cap is $1.2B with 341M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.51 $3.65 $1.77 - $3.89 $1.2B 341M 1.16M $0.05

GoodRx Financials Summary

As of 30-Jun-2026, GoodRx has a trailing 12-month revenue of $785M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,281,026 1,191,469 1,893,101 2,637,658
Revenue 785,230 796,853 792,324 750,265
EBITDA 164,231 173,428 130,647 76,653
Net Income 16,249 30,439 16,390 (8,868)
Total Assets 2,342,928 1,404,058 1,388,067 1,588,800
Total Debt 538,950 542,806 543,387 711,070
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GoodRx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GoodRx‘s full profile, request access.

Request a free trial

GoodRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the U
Enterprise Systems (Healthcare)
Santa Monica, CA
697 As of 2025

Boston, MA
 

Accra, Ghana
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GoodRx Competitors (7)

One of GoodRx’s 7 competitors is RxSense, a Private Equity-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RxSense Private Equity-Backed Boston, MA
mPharma Venture Capital-Backed Accra, Ghana
Blink Health Private Equity-Backed New York, NY
OptumRx Corporate Backed or Acquired Irvine, CA
Teladoc Health Formerly VC-backed New York, NY
You’re viewing 5 of 7 competitors. Get the full list »

GoodRx Patents

GoodRx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230395212-A1 Distributed system for logic-driven data routing Inactive 02-Jun-2022
US-20210074401-A1 Methods and systems to provide drug pricing information according to customer profile Inactive 03-Apr-2018
US-10073951-B2 Demographically filterable interface for conveying information about a medication Inactive 23-Jun-2014
US-20150370998-A1 Demographically filterable interface for conveying information about a medication Active 23-Jun-2014
US-10552575-B1 Medication monitoring and identification Active 07-Nov-2013 G16H20/10
To view GoodRx’s complete patent history, request access »

GoodRx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GoodRx Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GoodRx‘s full profile, request access.

Request a free trial

GoodRx Investments & Acquisitions (10)

GoodRx’s most recent deal was a Merger/Acquisition with ScriptDrop for . The deal was made on 16-Oct-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ScriptDrop 16-Oct-2025 Merger/Acquisition Clinics/Outpatient Services
Vivid Clear Rx (VCRx Business in Omaha, Nebraska) 13-Jan-2025 Merger/Acquisition Other Healthcare Services
VitaCare Prescription Services 14-Apr-2022 Merger/Acquisition Other Healthcare Technology Systems
flipMD 18-Feb-2022 Merger/Acquisition Consulting Services (B2B)
RxSaver 30-Apr-2021 Merger/Acquisition Media and Information Services (B2B)
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

GoodRx ESG

Risk Overview

Risk Rating

Updated November, 08, 2026

25.41 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Software & Services

Industry

of 898

Rank

Percentile

Internet Software and Services

Subindustry

of 177

Rank

Percentile

To view GoodRx’s complete esg history, request access »

GoodRx Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
ScriptDrop Columbus, OH 2016
Scriptcycle Asheville, NC 2012

GoodRx FAQs

  • When was GoodRx founded?

    GoodRx was founded in 2011.

  • Where is GoodRx headquartered?

    GoodRx is headquartered in Santa Monica, CA.

  • What is the size of GoodRx?

    GoodRx has 697 total employees.

  • What industry is GoodRx in?

    GoodRx’s primary industry is Enterprise Systems (Healthcare).

  • Is GoodRx a private or public company?

    GoodRx is a Public company.

  • What is GoodRx’s stock symbol?

    The ticker symbol for GoodRx is GDRX.

  • What is the current stock price of GoodRx?

    As of 12-Nov-2026 the stock price of GoodRx is $3.51.

  • What is the current market cap of GoodRx?

    The current market capitalization of GoodRx is $1.2B.

  • What is GoodRx’s current revenue?

    The trailing twelve month revenue for GoodRx is $785M.

  • Who are GoodRx’s competitors?

    RxSense, mPharma, Blink Health, OptumRx, and Teladoc Health are some of the 7 competitors of GoodRx.

  • What is GoodRx’s annual earnings per share (EPS)?

    GoodRx’s EPS for 12 months was $0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process